Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

FREELINE THERAPEUTICS HOLDINGS PLC

(FRLN)
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op FREELINE THERAPEUTICS HOLDINGS PLC
06/01Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/01Wall Street Set for Mixed Open After Fed-Induced Retreat
06/01Freeline Therapeutics ADRs Higher After FDA Clears IND for FLT201
06/01Freeline Therapeutics Holdings' Investigational New Drug Application for Gene Therapy F..
06/01FREELINE THERAPEUTICS : Announces FDA Clearance of Investigational New Drug Application - ..
06/01Freeline Announces FDA Clearance of Investigational New Drug Application for FLT201 for..
06/01Freeline Therapeutics Holdings plc Announces FDA Clearance of Investigational New Drug ..
04/01Freeline To Participate In Conferences During January 2022
2021Freeline Therapeutics To Reduce Workforce by 25%
2021FREELINE THERAPEUTICS : Announces 2022 Corporate Priorities and Guidance - Form 6-K
2021Freeline Announces 2022 Corporate Priorities and Guidance
2021FREELINE THERAPEUTICS : Presents Long-Term Follow-Up Data from Phase 1/2 B-AMAZE Trial in ..
2021Freeline Presents Long-Term Follow-Up Data from Phase†1/2 B-AMAZE Trial in Hemophilia B..
2021Freeline Therapeutics Holdings plc Presents Long-Term Follow-Up Data from Phase 1/2 B-A..
2021Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021Freeline to Participate in Evercore ISI 4th Annual HealthCONx Conference
2021Freeline to Participate in Stifel 2021 Virtual Healthcare Conference
2021Freeline Reports New Data from Fabry Disease Program, Pipeline and Company Updates, Inc..
2021Freeline Therapeutics Holdings plc Reports Earnings Results for the Nine Months Ended S..
2021Freeline Reports New Data from Fabry Disease Program, Pipeline and Company Updates, Inc..
2021Freeline Therapeutics Holdings plc Appoints Pamela Foulds as Chief Medical Officer
2021Freeline Therapeutics Holdings plc Announces New Data from its Ongoing Phase 1/2 Marvel..
2021Freeline Therapeutics to Present FLT180a Data at the 2021 ASH Annual Meeting
2021Freeline Therapeutics to Present FLT180a Data at the 2021 ASH Annual Meeting
2021Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021FREELINE THERAPEUTICS HOLDINGS PLC(N : FRLN) dropped from S&P Global BMI Index
2021FREELINE THERAPEUTICS : Files for Up to $250 Million Mixed-Securities Shelf
2021FREELINE THERAPEUTICS' : FLT201 Receives Orphan Drug Designations in US, EU
2021FREELINE THERAPEUTICS : Announces Orphan Drug Designations for FLT201 for the Treatment of..
2021FREELINE THERAPEUTICS : to Participate in Upcoming Investor Conferences in September 2021
2021Freeline Therapeutics Holdings plc Announces Chief Executive Officer Changes
2021FREELINE THERAPEUTICS : Appoints Michael J. Parini as Chief Executive Officer and Reports ..
2021FREELINE THERAPEUTICS : Appoints Michael J. Parini as Chief Executive Officer and Reports ..
2021Freeline Therapeutics Holdings plc Reports Unaudited Consolidated Earnings Results for ..
2021Freeline Therapeutics Holdings plc Announces Executive Changes
2021FREELINE THERAPEUTICS : Chief Medical Officer to Step Down
2021Freeline Therapeutics Holdings plc Announces Resignation Julie Krop as Chief Medical Of..
2021FREELINE THERAPEUTICS : Provides Executive Leadership Team Update; Company to Provide Corp..
2021Freeline Therapeutics Holdings plc Announces Executive Changes
2021ADRs End Lower; Luckin Coffee, Ambrx Among Companies Actively Trading
2021FREELINE THERAPEUTICS : Appointment of Chief Technical Operations Officer James Bircher co..
2021Freeline Announces Executive Leadership Changes
2021Freeline Therapeutics Holdings plc Announces Executive Leadership Changes
2021FREELINE THERAPEUTICS : Voting Results of Annual General Meeting (Form 6-K)
2021FREELINE THERAPEUTICS : Doses Second Patient in Phase 1/2 Trial of FLT190 to Treat Fabry D..
2021FREELINE THERAPEUTICS : Doses Second Patient of Phase 1/2 MARVEL-1 Clinical Trial for Fabr..
2021Freeline Doses Second Patient of Phase†1/2 MARVEL-1 Clinical Trial for Fabry Disease
2021Freeline Doses Second Patient of Phase 1/2 Marvel-1 Clinical Trial for Fabry Disease
2021FREELINE THERAPEUTICS : FLT190 Phase 1/2 dose-finding study in Fabry disease on track to d..
2021Freeline Reports First Quarter 2021 Financial Results and Recent Business Highlights
2021Freeline Therapeutics Holdings plc Reports Unaudited Consolidated Earnings Results for ..
2021Freeline Therapeutics Holdings plc Announces Executive Appointments
2021FREELINE THERAPEUTICS : to Participate at the 2021 RBC Capital Markets Global Healthcare C..
2021FREELINE THERAPEUTICS : Presents Data Highlighting Platform Technology at the American Soc..
2021Freeline Therapeutics Holdings plc Presents Data Highlighting Platform Technology At th..
2021Freeline to Present Data at the American Society of Gene and Cell Therapy Annual Meetin..
2021Freeline to Participate in Upcoming Investor Conferences in April and May 2021
2021Freeline Reports Full Year 2020 Financial Results and Business Highlights
2021Freeline Therapeutics Holdings plc Announces Executive Changes
2021Freeline Therapeutics Holdings plc Reports Consolidated Earnings Results for the Year E..
2021Freeline to Present at Upcoming Investor Conferences
2021FREELINE THERAPEUTICS : Appoints Colin Love, PhD to Board of Directors
2021Freeline Therapeutics Holdings plc Announces the Appointment of Colin A. Love to its Bo..
2021FREELINE THERAPEUTICS : to Present at Upcoming Investor Conferences
2021Freeline Therapeutics Names Michael Parini COO; CFO Resigns
2021FREELINE THERAPEUTICS : Announces Expansion of Executive Leadership
2021Freeline Therapeutics Holdings plc Announces Management Changes
2021Freeline Therapeutics Holdings plc Announces the Resignation of Brian M. Silver as Chie..
2021Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, ..
2021Freeline Presents Data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapie..
2021Freeline Therapeutics Holdings plc Presents Data on Its Gaucher Disease and Fabry Disea..
2021FREELINE THERAPEUTICS : Modifies FLT180a Hemophilia B Plan After FDA Feedback; Stock Decli..
2021Freeline Therapeutics Updates Clinical Development Plan for its FLT180a Hemophilia B Pr..
2021Freeline Therapeutics Updates Clinical Development Plan for its FLT180a Hemophilia B Pr..
1  2Volgende
Volgende evenement op FREELINE THERAPEUTICS HOLDINGS PLC
30/03/22